Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease.
about
Home versus hospital intravenous antibiotic therapy for cystic fibrosisAntibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosisAntibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosisHome versus hospital intravenous antibiotic therapy for cystic fibrosisAntibiotic treatment forStenotrophomonas maltophiliain people with cystic fibrosisNoisy neighbourhoods: quorum sensing in fungal-polymicrobial infectionsStenotrophomonas maltophilia: an emerging global opportunistic pathogenPhylogenomics and molecular signatures for species from the plant pathogen-containing order xanthomonadalesEffects of green tea compound epigallocatechin-3-gallate against Stenotrophomonas maltophilia infection and biofilmComparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis.Influenza vaccination in children with cystic fibrosis.Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infectionsEvaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of nonfermenting gram-negative bacilli isolated from cultures from cystic fibrosis patientsClinical significance of microbial infection and adaptation in cystic fibrosis.Stenotrophomonas maltophilia strains replicate and persist in the murine lung, but to significantly different degreesAlterations of lung microbiota in a mouse model of LPS-induced lung injuryHost-pathogen interplay in the respiratory environment of cystic fibrosis.Type II Secretion-Dependent Degradative and Cytotoxic Activities Mediated by Stenotrophomonas maltophilia Serine Proteases StmPr1 and StmPr2Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus.Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes.Stenotrophomonas maltophilia encodes a type II protein secretion system that promotes detrimental effects on lung epithelial cells.Influenza vaccination in children at high risk of respiratory disease.Year-in-review 2010: asthma, COPD, cystic fibrosis and airway biology.Update in cystic fibrosis 2010.Update in cystic fibrosis 2011.Current dilemmas in antimicrobial therapy in cystic fibrosis.Inhaled liposomal amikacin.Update on host-pathogen interactions in cystic fibrosis lung disease.Infection in cystic fibrosis: impact of the environment and climate.Isolation of Stenotrophomonas maltophilia in asymptomatic lung transplant recipients: effects of treatment on eradication and outcome.Incident Stenotrophomonas maltophilia infection and lung function decline in cystic fibrosis.Avibactam Restores the Susceptibility of Clinical Isolates of Stenotrophomonas maltophilia to Aztreonam.Clinical Outcomes Associated with Achromobacter Species Infection in Patients with Cystic Fibrosis.Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient.Comparative genomics of non-pseudomonal bacterial species colonising paediatric cystic fibrosis patients.In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression.Azithromycin use in patients with cystic fibrosis.In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients.A new method to improve the clinical evaluation of cystic fibrosis patients by mucus viscoelastic properties
P2860
Q24187116-E48C0D52-DAD4-4E2D-A677-556DA6203951Q24197517-283AC885-9D31-44CC-A688-BC1439636C9EQ24197766-8078AEAF-4875-4CE5-82AE-19DA3FF1E3BDQ24201353-6B9FAA81-8D31-4134-87AA-7852E429852DQ26471114-CA74C388-756A-49E5-BAB5-30C4FE839953Q26799027-978EDE3D-87AA-44F9-A5D9-679B3C5AD42AQ26995336-058D830F-B8BC-4491-8171-6B2D271949D3Q28486091-EC2145AA-6750-4226-AD1C-B8C0BF8A6354Q28541755-B1CAB6D9-69EF-4A22-B122-C31F0AAC6A11Q30413773-DCE2C691-0231-45C7-A001-FA58EF728F26Q30429062-6FDFF37F-883F-4C7D-B5C0-40A480F3DA67Q33786154-A513D743-58B9-490B-89A4-2AA49F090508Q34229243-66A0C81F-D91E-4ED0-A0CC-48F31F9F202AQ34491552-3513F297-39AD-411D-B6B3-CBE648AD8D59Q35199103-F52E779C-FE2F-44F3-B7A3-97849D8DD702Q35625939-A3EE1C13-1BCB-4426-AAB9-83AAB379F507Q35799736-67062517-F1D5-4708-9310-50694CC64205Q36053562-44794AEA-5B8B-4FB7-A764-34916CDB2EADQ36197194-0BCBE30A-C4B8-4584-A504-8EEE45C8EFF1Q36213685-FD00F6A1-E388-434B-96AA-85285D8FCBBEQ37065167-440EC56D-6989-45FD-89EE-6DBDE8A26CC6Q37123787-55E0BBFA-E383-4701-B691-00FE191731FEQ37668402-E6EC4A6A-AAEB-4A2A-86AD-093A89B7D270Q37845433-3A641049-7758-40B2-9B29-D28532EC34F1Q37892766-0E6B2B1F-BDCB-4822-BC0F-94FACDBD8234Q38006922-000CF580-2EC4-40B2-B01D-3D67972340A4Q38042719-5666D525-D506-4A6F-BF00-1A9B82991BB7Q38216555-CB23902E-D4F9-41E6-927D-5F0B2BE71A43Q38605085-E7753D3D-632F-4968-B536-815284EF7FD8Q38763542-25233903-4D4F-4F31-9C87-9738D7EE104FQ39740434-41553CA8-A76B-4457-8BD5-149D69702F5FQ40090307-0E6087E2-CF12-4696-A6DC-16729379A30FQ40091720-44569BB4-D03E-4457-91A5-A2A26A0CE41CQ40252432-E932FC5E-A1B4-46DC-8F44-7E9A1D58E222Q40504881-503F83D8-7049-4D13-96F9-D629E436ACF0Q40507596-EF4E0879-89A5-4A96-AD85-EA87BFCA4B0DQ40652733-8957B5E1-A0E5-4DEE-8561-3573F465526FQ41428470-C4CBBFD3-494D-49B7-9046-829043E0F748Q41687440-BE2DE8A0-EED5-4F6C-AAAC-731E785B1432Q41809734-7E633392-9974-4FC5-9CC4-47891EB8A250
P2860
Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Stenotrophomonas maltophilia i ...... se and effect on lung disease.
@en
Stenotrophomonas maltophilia i ...... se and effect on lung disease.
@nl
type
label
Stenotrophomonas maltophilia i ...... se and effect on lung disease.
@en
Stenotrophomonas maltophilia i ...... se and effect on lung disease.
@nl
prefLabel
Stenotrophomonas maltophilia i ...... se and effect on lung disease.
@en
Stenotrophomonas maltophilia i ...... se and effect on lung disease.
@nl
P2093
P2860
P1476
Stenotrophomonas maltophilia i ...... se and effect on lung disease.
@en
P2093
Elizabeth Tullis
Ian Crandall
Stephanie Tom
Sudha Prasad
Valerie Waters
Yvonne Yau
P2860
P304
P356
10.1164/RCCM.201009-1392OC
P407
P577
2010-10-01T00:00:00Z